INTRODUCTION
In 1983, a Gram-negative bacterium, Helicobacter pylori (H. pylori), was firstly discovered [1] . Despite the infection of H. pylori is very common in developing countries, it was distributed worldwide [2] . Colonization of H. pylori in the stomach is associated with many pathogenic effects in the upper gastrointestinal tract, e.g. gastric cancer, peptic ulcer disease, mucosaassociated lymphoid tissue (MALT) lymphoma and chronic gastritis [3] . Moreover, H. pylori positivity has been linked to several diseases, such as idiopathic iron deficiency anemia [4] , idiopathic thrombocytopenic purpura [5] , ischemic heart disease [6], autoimmune pancreatitis [7] [8] [9] , acute coronary syndromes [10] , and hepatobiliary diseases [11 -13] .
Recent reviews have collected data emphasized the capability of H. pylori to induce and increase the severity of the liver pathogenesis [1, 14] . Previous reports tried to explain how H. pylori colonize the liver. Some manuscripts clarified that upon the occurring of portal hypertension during the later stages of chronic liver disease, H. pylori could trans-located from the stomach into the blood through the portal system and then the bacteria DNA could be detected in the liver tissues 
MATERIALS AND METHODS

Ethical statement
The present study was conducted in accordance with the Declaration of Helsinki and the Guidelines for Good Clinical Practice and approved by the ethical committee of Faculty of Medicine, Al-Azhar University and Kafer El Shiekh Liver and Heart Institute, Egypt. The purpose and procedures involved in the present study were explained and written informed consent was obtained from all participants. 
Study population
Hematological and biochemical analysis
Complete blood count (CBC) was determined using an automated hematology analyzer XP series (Sysmex, Japan). Direct, total bilirubin, albumin, fasting sugar, alanine transaminase (ALT), aspartate transaminase (AST) and creatinine were run on using ABX Pentra C400 clinical chemistry analyzer (Horiba ABX SAS, Montpellier, France). Alpha-fetoprotein (AFP) and antinuclear antibody (ANA) were determined using chemiluminescent immunoassay (Liaison, DiaSorin, Germany). Thyroid-stimulating hormone (TSH) was detected using (Teco Diagnostics, CA, USA). International normalized ratio (INR) was done automatically using a commercial kit (Siemens Healthcare Diagnostic Inc., Germany). In all 185 patients, compensated cirrhosis was determined by Fibroscan™ >12.5 kPa. In the HCV chronically infected patients subjected to a liver biopsy compensated cirrhosis was also determined by biopsy of METAVIR 4 or Ishak more than or equal 5. 
Statistical analysis
RESULTS
Helicopacter pylori infection among Egyptian HCV patients was summarized in Table 1 . Overall prevalence was 10.81%, and 8.00%, using ELISA, and IHC, respectively. The seroprevalence was significantly (P<0.05) increased among the HCV patients from Gharbiya province 15.66% when compared to Kafr El Sheikh province 6.86%. Similarly, IHC demonstrated significant higher levels of H. pylori infection among HCV patients Gharbiya province 10.53% compared to Kafr El Sheikh province 4.65%. H. pylori infection was detected in the liver of HCV patients as represented in Fig. 1 .
During the H. pylori detection among Egyptian HCV patients, the results of the ELISA were cross-tabulated with those of IHC and summarized in Table 2 . Among one hundred HCV patients, the agreement percentage between the results of ELISA, and those of IHC was 96%. Table 3 demonstrated the relation between H. pylori positivity and age, gender, and residence among Egyptian HCV patients. According to residence, the bacteria prevalence was nonsignificantly lower (P>0.05) in the rural areas, 6.74%, 2.70% than the urban areas, 12.50%, and 11.11% using ELISA and IHC, respectively. Although, higher prevalence was recorded in male and younger patients compared to female and older patients, no significant difference was detected in the prevalence of H. pylori among HCV patients based on gender and age, using ELISA, or IHC.
Characteristics of cirrhosis, HCV RNA load and biochemical data of the study population were shown in Table 4 . Liver cirrhosis and at patient with concomitant H. pylori and chronic HCV infections showed a higher percentage compared to those patients with chronic HCV mono-infection. Similar patterns were detected at the levels of HCV RNA load among the study populations. Furthermore, similar patterns were detected at the levels of AFP, TSH, glucose, INR, AST, ALT, direct, total bilirubin, albumin, creatinine and ANA among the study populations.
Hematological findings of the study population were illustrated in Tables 5. Minimal significant increase (P<0.05) was detected in the current study, at the level of relative lymphocyte counts in patients with concomitant H. pylori and chronic HCV infections immunohistochemically detected compared to those patients with chronic HCV mono-infection. No significant alterations were determined on the levels of the other examined hematological parameters (Table 5) . 
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Data are expressed as: mean ± standard error (STE) or number (% among study population). 
DISCUSSION
In the current study, H. pylori prevalence in 185 HCV infected individuals from Gharbiya and Kafr El Sheikh provinces was examined by ELISA, and from those cases one hundred HCV infected patients were examined using IHC. The overall prevalence of H. pylori was 10.81%, and 8.00% using ELISA, and IHC, respectively. According to the area, significant high H. pylori prevalence was detected among patients from Gharbiya province compared to those from Kafr El Sheikh province using ELISA, and IHC, respectively. In Tanta Generally, low prevalence was detected for microbes using IHC or PCR compared to serological assays. The weak reliability of the IHC assays might be rendered to low numbers of the bacteria in the tested human tissues, small sample size of the collected tissue, and may be, randomized distribution of bacterial units. Although a high agreement between the results of ELISA, and IHC was demonstrated in this study, IHC detected lower positivity than ELISA. The lower positivity detected by the microscopic examination could be attributed to the previously mentioned sampling issues. Furthermore, the antibody response is always independent of bacterial burden. In conclusion, the present study indicated that H. pylori infection is frequent in Egypt, with noticeable prevalence among HCV patients. Regular screening and treatment for H. pylori among HCV patients is important.
Ethical approval:Approved .
Conflict of interest
The authors declare that they have no competing interests.
